{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:57:10Z","timestamp":1776121030072,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00192-020-04620-x","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T16:02:29Z","timestamp":1606579349000},"page":"2337-2347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Regenerative medicine for anal incontinence: a review of regenerative therapies beyond cells"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7429-7060","authenticated-orcid":false,"given":"Andre","family":"Plair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Bennington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Koudy","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candace","family":"Parker-Autry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine Ann","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopal","family":"Badlani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,28]]},"reference":[{"issue":"8","key":"4620_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10350-004-0593-0","volume":"47","author":"AK Macmillan","year":"2004","unstructured":"Macmillan AK, et al. The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature. Dis Colon Rectum. 2004;47(8):1341\u20139.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"4620_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.gastro.2005.04.006","volume":"129","author":"AE Bharucha","year":"2005","unstructured":"Bharucha AE, et al. Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology. 2005;129(1):42\u20139.","journal-title":"Gastroenterology"},{"issue":"12","key":"4620_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S1701-2163(16)30081-0","volume":"37","author":"MA Harvey","year":"2015","unstructured":"Harvey MA, et al. Obstetrical anal sphincter injuries (OASIS): prevention, recognition, and repair. J Obstet Gynaecol Can. 2015;37(12):1131\u201348.","journal-title":"J Obstet Gynaecol Can"},{"issue":"8","key":"4620_CR4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/j.1471-0528.1985.tb03053.x","volume":"92","author":"SJ Snooks","year":"1985","unstructured":"Snooks SJ, Henry MM, Swash M. Faecal incontinence due to external anal sphincter division in childbirth is associated with damage to the innervation of the pelvic floor musculature: a double pathology. Br J Obstet Gynaecol. 1985;92(8):824\u20138.","journal-title":"Br J Obstet Gynaecol"},{"issue":"9","key":"4620_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1471-0528.1990.tb02570.x","volume":"97","author":"RE Allen","year":"1990","unstructured":"Allen RE, et al. Pelvic floor damage and childbirth: a neurophysiological study. Br J Obstet Gynaecol. 1990;97(9):770\u20139.","journal-title":"Br J Obstet Gynaecol"},{"issue":"9","key":"4620_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1055\/s-2007-994328","volume":"14","author":"DA Sandridge","year":"1997","unstructured":"Sandridge DA, et al. Vaginal delivery is associated with occult disruption of the anal sphincter mechanism. Am J Perinatol. 1997;14(9):527\u201333.","journal-title":"Am J Perinatol"},{"issue":"4 Pt 1","key":"4620_CR7","first-page":"527","volume":"82","author":"LA Crawford","year":"1993","unstructured":"Crawford LA, et al. Incontinence following rupture of the anal sphincter during delivery. Obstet Gynecol. 1993;82(4 Pt 1):527\u201331.","journal-title":"Obstet Gynecol"},{"key":"4620_CR8","first-page":"CD002116","volume":"6","author":"MI Omar","year":"2013","unstructured":"Omar MI, Alexander CE. Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 2013;6:CD002116.","journal-title":"Cochrane Database Syst Rev"},{"key":"4620_CR9","first-page":"CD001757","volume":"7","author":"SR Brown","year":"2013","unstructured":"Brown SR, Wadhawan H, Nelson RL. Surgery for faecal incontinence in adults. Cochrane Database Syst Rev. 2013;7:CD001757.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9770","key":"4620_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0140-6736(10)62297-0","volume":"377","author":"W Graf","year":"2011","unstructured":"Graf W, et al. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet. 2011;377(9770):997\u20131003.","journal-title":"Lancet"},{"issue":"3","key":"4620_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/SLA.0b013e3181cf8ed0","volume":"251","author":"SD Wexner","year":"2010","unstructured":"Wexner SD, et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg. 2010;251(3):441\u20139.","journal-title":"Ann Surg"},{"issue":"6","key":"4620_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00384-014-1882-2","volume":"29","author":"TJ Lam","year":"2014","unstructured":"Lam TJ, et al. Clinical response and sustainability of treatment with temperature-controlled radiofrequency energy (Secca) in patients with faecal incontinence: 3 years follow-up. Int J Color Dis. 2014;29(6):755\u201361.","journal-title":"Int J Color Dis"},{"issue":"10","key":"4620_CR13","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/sctm.16-0484","volume":"6","author":"M Majka","year":"2017","unstructured":"Majka M, et al. Concise review: mesenchymal stem cells in cardiovascular regeneration: emerging research directions and clinical applications. Stem Cells Transl Med. 2017;6(10):1859\u201367.","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"4620_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrgastro.2016.124","volume":"13","author":"KN Bitar","year":"2016","unstructured":"Bitar KN, Zakhem E. Bioengineering the gut: future prospects of regenerative medicine. Nat Rev Gastroenterol Hepatol. 2016;13(9):543\u201356.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"4620_CR15","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.juro.2016.05.136","volume":"196","author":"JK Williams","year":"2016","unstructured":"Williams JK, et al. Regenerative medicine therapies for stress urinary incontinence. J Urol. 2016;196(6):1619\u201326.","journal-title":"J Urol"},{"issue":"5","key":"4620_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/DCR.0000000000000548","volume":"59","author":"L Sun","year":"2016","unstructured":"Sun L, et al. Electrical stimulation followed by mesenchymal stem cells improves anal sphincter anatomy and function in a rat model at a time remote from injury. Dis Colon Rectum. 2016;59(5):434\u201342.","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"4620_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00192-014-2496-5","volume":"26","author":"JL Fitzwater","year":"2015","unstructured":"Fitzwater JL, et al. Effect of myogenic stem cells on the integrity and histomorphology of repaired transected external anal sphincter. Int Urogynecol J. 2015;26(2):251\u20136.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"4620_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10350-007-9153-8","volume":"51","author":"B Lorenzi","year":"2008","unstructured":"Lorenzi B, et al. Treatment of experimental injury of anal sphincters with primary surgical repair and injection of bone marrow-derived mesenchymal stem cells. Dis Colon Rectum. 2008;51(4):411\u201320.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"4620_CR19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00192-014-2620-6","volume":"26","author":"TI Montoya","year":"2015","unstructured":"Montoya TI, et al. Myogenic stem cell-laden hydrogel scaffold in wound healing of the disrupted external anal sphincter. Int Urogynecol J. 2015;26(6):893\u2013904.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"4620_CR20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/AOG.0b013e3181d56cc5","volume":"115","author":"AB White","year":"2010","unstructured":"White AB, et al. Effect of myogenic stem cells on contractile properties of the repaired and unrepaired transected external anal sphincter in an animal model. Obstet Gynecol. 2010;115(4):815\u201323.","journal-title":"Obstet Gynecol"},{"key":"4620_CR21","doi-asserted-by":"publisher","first-page":"612946","DOI":"10.1155\/2012\/612946","volume":"2012","author":"M Cruz","year":"2012","unstructured":"Cruz M, et al. Pelvic organ distribution of mesenchymal stem cells injected intravenously after simulated childbirth injury in female rats. Obstet Gynecol Int. 2012;2012:612946.","journal-title":"Obstet Gynecol Int"},{"issue":"1","key":"4620_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/AOG.0b013e3182397009","volume":"119","author":"SD Pathi","year":"2012","unstructured":"Pathi SD, et al. Recovery of the injured external anal sphincter after injection of local or intravenous mesenchymal stem cells. Obstet Gynecol. 2012;119(1):134\u201344.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"4620_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.scr.2012.10.002","volume":"10","author":"L Salcedo","year":"2013","unstructured":"Salcedo L, et al. Mesenchymal stem cells can improve anal pressures after anal sphincter injury. Stem Cell Res. 2013;10(1):95\u2013102.","journal-title":"Stem Cell Res"},{"issue":"6","key":"4620_CR24","doi-asserted-by":"publisher","first-page":"760","DOI":"10.5966\/sctm.2013-0157","volume":"3","author":"L Salcedo","year":"2014","unstructured":"Salcedo L, et al. Functional outcome after anal sphincter injury and treatment with mesenchymal stem cells. Stem Cells Transl Med. 2014;3(6):760\u20137.","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"4620_CR25","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00384-011-1269-6","volume":"26","author":"L Salcedo","year":"2011","unstructured":"Salcedo L, et al. Chemokine upregulation in response to anal sphincter and pudendal nerve injury: potential signals for stem cell homing. Int J Color Dis. 2011;26(12):1577\u201381.","journal-title":"Int J Color Dis"},{"issue":"11","key":"4620_CR26","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1097\/DCR.0b013e3182a4adfb","volume":"56","author":"FL Lane","year":"2013","unstructured":"Lane FL, et al. In vivo recovery of the injured anal sphincter after repair and injection of myogenic stem cells: an experimental model. Dis Colon Rectum. 2013;56(11):1290\u20137.","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"4620_CR27","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/DCR.0b013e3181b55112","volume":"52","author":"M Aghaee-Afshar","year":"2009","unstructured":"Aghaee-Afshar M, et al. Potential of human umbilical cord matrix and rabbit bone marrow-derived mesenchymal stem cells in repair of surgically incised rabbit external anal sphincter. Dis Colon Rectum. 2009;52(10):1753\u201361.","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"4620_CR28","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/DCR.0b013e3181e53088","volume":"53","author":"AM Kajbafzadeh","year":"2010","unstructured":"Kajbafzadeh AM, et al. Functional external anal sphincter reconstruction for treatment of anal incontinence using muscle progenitor cell auto grafting. Dis Colon Rectum. 2010;53(10):1415\u201321.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"4620_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/DCR.0000000000000346","volume":"58","author":"HK Oh","year":"2015","unstructured":"Oh HK, et al. Functional and histological evidence for the targeted therapy using biocompatible polycaprolactone beads and autologous myoblasts in a dog model of fecal incontinence. Dis Colon Rectum. 2015;58(5):517\u201325.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"4620_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/gut.2009.181347","volume":"59","author":"A Frudinger","year":"2010","unstructured":"Frudinger A, et al. Muscle-derived cell injection to treat anal incontinence due to obstetric trauma: pilot study with 1 year follow-up. Gut. 2010;59(1):55\u201361.","journal-title":"Gut"},{"issue":"9","key":"4620_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/codi.12947","volume":"17","author":"A Frudinger","year":"2015","unstructured":"Frudinger A, et al. Autologous skeletal-muscle-derived cell injection for anal incontinence due to obstetric trauma: a 5-year follow-up of an initial study of 10 patients. Color Dis. 2015;17(9):794\u2013801.","journal-title":"Color Dis"},{"issue":"3","key":"4620_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00192-016-3064-y","volume":"28","author":"S Gras","year":"2017","unstructured":"Gras S, Tolstrup CK, Lose G. Regenerative medicine provides alternative strategies for the treatment of anal incontinence. Int Urogynecol J. 2017;28(3):341\u201350.","journal-title":"Int Urogynecol J"},{"key":"4620_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/asheducation-2003.1.419","volume":"2003","author":"MH Cottler-Fox","year":"2003","unstructured":"Cottler-Fox MH, et al. Stem cell mobilization. Hematology Am Soc Hematol Educ Program. 2003;2003:419\u201337.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"9","key":"4620_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0301-472X(02)00883-4","volume":"30","author":"T Lapidot","year":"2002","unstructured":"Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30(9):973\u201381.","journal-title":"Exp Hematol"},{"key":"4620_CR35","doi-asserted-by":"crossref","first-page":"7060975","DOI":"10.1155\/2016\/7060975","volume":"2016","author":"S Zhou","year":"2016","unstructured":"Zhou S, et al. Stem cell therapy for treatment of stress urinary incontinence: the current status and challenges. Stem Cells Int. 2016;2016:7060975.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4620_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13287-016-0411-3","volume":"7","author":"JK Williams","year":"2016","unstructured":"Williams JK, et al. Local versus intravenous injections of skeletal muscle precursor cells in nonhuman primates with acute or chronic intrinsic urinary sphincter deficiency. Stem Cell Res Ther. 2016;7(1):147.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"4620_CR37","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.juro.2016.05.106","volume":"196","author":"JK Williams","year":"2016","unstructured":"Williams JK, et al. Cell versus chemokine therapy in a nonhuman primate model of chronic intrinsic urinary sphincter deficiency. J Urol. 2016;196(6):1809\u201315.","journal-title":"J Urol"},{"issue":"4","key":"4620_CR38","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/DCR.0000000000000783","volume":"60","author":"L Sun","year":"2017","unstructured":"Sun L, et al. Regenerating the anal sphincter: cytokines, stem cells, or both? Dis Colon Rectum. 2017;60(4):416\u201325.","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"4620_CR39","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/sctm.16-0497","volume":"6","author":"J Koudy Williams","year":"2017","unstructured":"Koudy Williams J, et al. Efficacy and initial safety profile of CXCL12 treatment in a rodent model of urinary sphincter deficiency. Stem Cells Transl Med. 2017;6(8):1740\u20136.","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"4620_CR40","doi-asserted-by":"publisher","first-page":"F92","DOI":"10.1152\/ajprenal.00510.2014","volume":"308","author":"K Deng","year":"2015","unstructured":"Deng K, et al. Mesenchymal stem cells and their secretome partially restore nerve and urethral function in a dual muscle and nerve injury stress urinary incontinence model. Am J Physiol Renal Physiol. 2015;308(2):F92\u2013F100.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"4620_CR41","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s10350-008-9360-y","volume":"51","author":"SB Kang","year":"2008","unstructured":"Kang SB, et al. Sphincter contractility after muscle-derived stem cells autograft into the cryoinjured anal sphincters of rats. Dis Colon Rectum. 2008;51(9):1367\u201373.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"4620_CR42","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00404-013-3028-0","volume":"288","author":"M Aref-Adib","year":"2013","unstructured":"Aref-Adib M, et al. Stem cell therapy for stress urinary incontinence: a systematic review in human subjects. Arch Gynecol Obstet. 2013;288(6):1213\u201321.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"4620_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/SPV.0b013e3182a331a9","volume":"19","author":"AK Hijaz","year":"2013","unstructured":"Hijaz AK, et al. Stem cell homing factor, CCL7, expression in mouse models of stress urinary incontinence. Female Pelvic Med Reconstr Surg. 2013;19(6):356\u201361.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"4","key":"4620_CR44","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.juro.2012.09.096","volume":"189","author":"AT Lenis","year":"2013","unstructured":"Lenis AT, et al. Impact of parturition on chemokine homing factor expression in the vaginal distention model of stress urinary incontinence. J Urol. 2013;189(4):1588\u201394.","journal-title":"J Urol"},{"issue":"6","key":"4620_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/SPV.0000000000000394","volume":"23","author":"BM Couri","year":"2017","unstructured":"Couri BM, et al. Effect of pregnancy and delivery on cytokine expression in a mouse model of pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2017;23(6):449\u201356.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"11","key":"4620_CR46","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/jth.12404","volume":"11","author":"M Chatterjee","year":"2013","unstructured":"Chatterjee M, Gawaz M. Platelet-derived CXCL12 (SDF-1alpha): basic mechanisms and clinical implications. J Thromb Haemost. 2013;11(11):1954\u201367.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"4620_CR47","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1158\/1078-0432.CCR-10-2636","volume":"17","author":"DG Duda","year":"2011","unstructured":"Duda DG, et al. CXCL12 (SDF1alpha)-CXCR4\/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res. 2011;17(8):2074\u201380.","journal-title":"Clin Cancer Res"},{"key":"4620_CR48","first-page":"144","volume":"8","author":"R Wurth","year":"2014","unstructured":"Wurth R, et al. CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment. Front Cell Neurosci. 2014;8:144.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"4620_CR49","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP. CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res. 2010;16(11):2927\u201331.","journal-title":"Clin Cancer Res"},{"key":"4620_CR50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fimmu.2015.00429","volume":"6","author":"L Pawig","year":"2015","unstructured":"Pawig L, et al. Diversity and inter-connections in the CXCR4 chemokine receptor\/ligand family: molecular perspectives. Front Immunol. 2015;6:429.","journal-title":"Front Immunol"},{"issue":"19","key":"4620_CR51","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1158\/1078-0432.CCR-14-0914","volume":"21","author":"S Scala","year":"2015","unstructured":"Scala S. Molecular pathways: targeting the CXCR4-CXCL12 Axis--untapped potential in the tumor microenvironment. Clin Cancer Res. 2015;21(19):4278\u201385.","journal-title":"Clin Cancer Res"},{"issue":"5403","key":"4620_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1126\/science.283.5403.845","volume":"283","author":"A Peled","year":"1999","unstructured":"Peled A, et al. Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4. Science. 1999;283(5403):845\u20138.","journal-title":"Science"},{"issue":"1","key":"4620_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1084\/jem.185.1.111","volume":"185","author":"A Aiuti","year":"1997","unstructured":"Aiuti A, et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185(1):111\u201320.","journal-title":"J Exp Med"},{"issue":"11","key":"4620_CR54","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1182\/blood.V95.11.3289","volume":"95","author":"A Peled","year":"2000","unstructured":"Peled A, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial\/stromal migration and engraftment of NOD\/SCID mice. Blood. 2000;95(11):3289\u201396.","journal-title":"Blood"},{"issue":"1","key":"4620_CR55","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jtcvs.2012.09.080","volume":"145","author":"JW MacArthur Jr","year":"2013","unstructured":"MacArthur JW Jr, et al. Mathematically engineered stromal cell-derived factor-1alpha stem cell cytokine analog enhances mechanical properties of infarcted myocardium. J Thorac Cardiovasc Surg. 2013;145(1):278\u201384.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"4620_CR56","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/CIRCRESAHA.111.300440","volume":"112","author":"MS Penn","year":"2013","unstructured":"Penn MS, et al. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013;112(5):816\u201325.","journal-title":"Circ Res"},{"key":"4620_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.22203\/eCM.v022a09","volume":"22","author":"D Kuraitis","year":"2011","unstructured":"Kuraitis D, et al. A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. Eur Cell Mater. 2011;22:109\u201323.","journal-title":"Eur Cell Mater"},{"issue":"4","key":"4620_CR58","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/MOU.0000000000000632","volume":"29","author":"BM Balog","year":"2019","unstructured":"Balog BM, et al. Electrical stimulation for neuroregeneration in urology: a new therapeutic paradigm. Curr Opin Urol. 2019;29(4):458\u201365.","journal-title":"Curr Opin Urol"},{"issue":"6","key":"4620_CR59","doi-asserted-by":"publisher","first-page":"F1555","DOI":"10.1152\/ajprenal.00431.2017","volume":"315","author":"HH Jiang","year":"2018","unstructured":"Jiang HH, et al. Electrical stimulation of the pudendal nerve promotes neuroregeneration and functional recovery from stress urinary incontinence in a rat model. Am J Physiol Renal Physiol. 2018;315(6):F1555\u201364.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"4620_CR60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00384-011-1324-3","volume":"27","author":"L Salcedo","year":"2012","unstructured":"Salcedo L, et al. Low current electrical stimulation upregulates cytokine expression in the anal sphincter. Int J Color Dis. 2012;27(2):221\u20135.","journal-title":"Int J Color Dis"},{"issue":"1","key":"4620_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000355472","volume":"23","author":"P Romeo","year":"2014","unstructured":"Romeo P, et al. Extracorporeal shock wave therapy in musculoskeletal disorders: a review. Med Princ Pract. 2014;23(1):7\u201313.","journal-title":"Med Princ Pract"},{"issue":"1","key":"4620_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00019501-200602000-00011","volume":"17","author":"Y Fukumoto","year":"2006","unstructured":"Fukumoto Y, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis. 2006;17(1):63\u201370.","journal-title":"Coron Artery Dis"},{"issue":"2","key":"4620_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.eururo.2016.05.050","volume":"71","author":"Z Lu","year":"2017","unstructured":"Lu Z, et al. Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis. Eur Urol. 2017;71(2):223\u201333.","journal-title":"Eur Urol"},{"issue":"4","key":"4620_CR64","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jsxm.2017.02.004","volume":"14","author":"G Lin","year":"2017","unstructured":"Lin G, et al. In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy. J Sex Med. 2017;14(4):493\u2013501.","journal-title":"J Sex Med"},{"issue":"9","key":"4620_CR65","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/sctm.17-0282","volume":"7","author":"G Bauer","year":"2018","unstructured":"Bauer G, Elsallab M, Abou-El-Enein M. Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions. Stem Cells Transl Med. 2018;7(9):676\u201385.","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"4620_CR66","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1056\/NEJMc1600188","volume":"375","author":"AL Berkowitz","year":"2016","unstructured":"Berkowitz AL, et al. Glioproliferative lesion of the spinal cord as a complication of \"stem-cell tourism\". N Engl J Med. 2016;375(2):196\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"4620_CR67","doi-asserted-by":"publisher","first-page":"e1000029","DOI":"10.1371\/journal.pmed.1000029","volume":"6","author":"N Amariglio","year":"2009","unstructured":"Amariglio N, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009;6(2):e1000029.","journal-title":"PLoS Med"},{"issue":"5","key":"4620_CR68","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer UM, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009;18(5):683\u201392.","journal-title":"Stem Cells Dev"},{"issue":"6","key":"4620_CR69","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00395-004-0558-z","volume":"100","author":"HC Ott","year":"2005","unstructured":"Ott HC, McCue J, Taylor DA. Cell-based cardiovascular repair--the hurdles and the opportunities. Basic Res Cardiol. 2005;100(6):504\u201317.","journal-title":"Basic Res Cardiol"},{"issue":"11","key":"4620_CR70","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s40264-014-0226-z","volume":"37","author":"BA Baldo","year":"2014","unstructured":"Baldo BA. Side effects of cytokines approved for therapy. Drug Saf. 2014;37(11):921\u201343.","journal-title":"Drug Saf"},{"issue":"8","key":"4620_CR71","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1016\/j.biomaterials.2013.12.011","volume":"35","author":"M Song","year":"2014","unstructured":"Song M, et al. Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide ac-SDKP. Biomaterials. 2014;35(8):2436\u201345.","journal-title":"Biomaterials"},{"issue":"4","key":"4620_CR72","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/wrr.12552","volume":"25","author":"H Liu","year":"2017","unstructured":"Liu H, et al. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells. Wound Repair Regen. 2017;25(4):652\u201364.","journal-title":"Wound Repair Regen"},{"issue":"10","key":"4620_CR73","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1002\/jbm.a.36130","volume":"105","author":"M Shafiq","year":"2017","unstructured":"Shafiq M, Kong D, Kim SH. SDF-1alpha peptide tethered polyester facilitates tissue repair by endogenous cell mobilization and recruitment. J Biomed Mater Res A. 2017;105(10):2670\u201384.","journal-title":"J Biomed Mater Res A"},{"issue":"3","key":"4620_CR74","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.pharmthera.2014.03.009","volume":"143","author":"DI Bromage","year":"2014","unstructured":"Bromage DI, Davidson SM, Yellon DM. Stromal derived factor 1alpha: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther. 2014;143(3):305\u201315.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"4620_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/CIRCHEARTFAILURE.110.960302","volume":"4","author":"S Kanki","year":"2011","unstructured":"Kanki S, et al. Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail. 2011;4(4):509\u201318.","journal-title":"Circ Heart Fail"},{"issue":"4","key":"4620_CR76","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/jcsm.12092","volume":"7","author":"K Kowalski","year":"2016","unstructured":"Kowalski K, et al. Stromal derived factor-1 and granulocyte-colony stimulating factor treatment improves regeneration of Pax7\u2212\/\u2212 mice skeletal muscles. J Cachexia Sarcopenia Muscle. 2016;7(4):483\u201396.","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04620-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-020-04620-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04620-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T06:19:18Z","timestamp":1723961958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-020-04620-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4620"],"URL":"https:\/\/doi.org\/10.1007\/s00192-020-04620-x","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,28]]},"assertion":[{"value":"16 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Andre Plair, grant support from Neomedic.Julie Bennington, supported by NIH Post-doctoral T32 Institutional Training Grant \u201cLaboratory Animal and Comparative Medicine Research\u201d (NIH T32 OD010957).James Koudy Williams, None.Candace Parker-Autry, None.Catherine Ann Matthews, consultant for Boston Scientific and Pelvalon; grant support from Boston Scientific and Neomedic; expert defense for Johnson and Johnson.Gopal Badlani, advisory panelist for Olympus and Neotract; board of directors of AAGUS, and Urology Care Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}